Diagnos Laboratorium (Indonesia) Management Evaluation
| DGNS Stock | IDR 224.00 4.00 1.75% |
Diagnos Laboratorium employs about 568 people. The company is managed by 4 executives with a total tenure of roughly 1326 years, averaging almost 331.0 years of service per executive, having 142.0 employees per reported executive. Inspection of Diagnos Laboratorium's management performance can provide insight into the company performance.
| Fanfan Riksani Insider Co Sec |
| R Ridwan Insider Head Unit |
Diagnos |
Diagnos Laboratorium Management Team Effectiveness
The company has return on total asset (ROA) of 0.0297 % which means that it generated a profit of $0.0297 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0603 %, meaning that it generated $0.0603 on every $100 dollars invested by stockholders. Diagnos Laboratorium's management efficiency ratios could be used to measure how well Diagnos Laboratorium manages its routine affairs as well as how well it operates its assets and liabilities.Diagnos Laboratorium Workforce Comparison
Diagnos Laboratorium Utama is one of the top stocks in number of employees category among its peers. The total workforce of Diagnostics & Research industry is currently estimated at about 35,891. Diagnos Laboratorium claims roughly 568 in number of employees contributing just under 2% to equities under Diagnostics & Research industry.
The company has Profit Margin (PM) of 0.06 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06. Diagnos Laboratorium Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Diagnos Laboratorium Price Series Summation is a cross summation of Diagnos Laboratorium price series and its benchmark/peer.
Diagnos Laboratorium Notable Stakeholders
A Diagnos Laboratorium stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Diagnos Laboratorium often face trade-offs trying to please all of them. Diagnos Laboratorium's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Diagnos Laboratorium's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Fanfan Riksani | Co Sec | Profile | |
| R Ridwan | Head Unit | Profile | |
| Dennis Jacobus | Medical Director | Profile | |
| Mesha Sini | Pres Director | Profile |
About Diagnos Laboratorium Management Performance
The success or failure of an entity such as Diagnos Laboratorium often depends on how effective the management is. Diagnos Laboratorium management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Diagnos management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Diagnos management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia. Diagnos Laboratorium operates under Diagnostics Research classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 406 people.
Diagnos Laboratorium Workforce Analysis
Traditionally, organizations such as Diagnos Laboratorium use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Diagnos Laboratorium within its industry.Diagnos Laboratorium Manpower Efficiency
Return on Diagnos Laboratorium Manpower
| Revenue Per Employee | 532M | |
| Revenue Per Executive | 75.5B | |
| Net Income Per Employee | 113.2M | |
| Net Income Per Executive | 16.1B |
Other Information on Investing in Diagnos Stock
Diagnos Laboratorium financial ratios help investors to determine whether Diagnos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagnos with respect to the benefits of owning Diagnos Laboratorium security.